The effect of FK506 versus cyclosporine on glucose and lipid metabolism—a randomized trial

Transplantation

Volumn 58, Issue 6, 1994, Pages 669-674

  Steinmüller, Thomas M ^a   Graf, Klaus Jürgen ^b   Schleicher, Jan ^b   Leder, Korinna ^b   Bechstein, Wolf O ^b   Mueller, Andrea R ^b   Dette, Kai ^a   Schulz, Eckard ^b   Neuhaus, Peter ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C PEPTIDE; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN A; GLUCAGON; GLUCOSE; INSULIN; LIPID; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LIPID METABOLISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CHOLESTEROL; CYCLOSPORINE; FEMALE; GLUCAGON; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPIDS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS; TRIGLYCERIDES;

EID: 0028172568     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199409270-00006     Document Type: Article

References (32)

1. Starzl TE, Todo S, Fung J, et al. FK 506 for liver, kidney and pancreas transplantation. Lancet 1989; 2: 1000.
2. Starzl TE, Iwatzuki S, Shaw BW, Gordon RD. Orthotopic liver transplantation. Transplant Proc 1983; 15: 2463.
3. Fung J, Todo S, Jain A, et al. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 1990; 22 (suppl. 1): 6.
4. Starzl TE. Experience in renal transplantation Philadelphia; Saunders, 1964.
5. Boudreaux JP, McHugh L, Canafax DM, et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987; 44: 376.
6. Andersson A, Borg H, Hallberg A, et al. Long-term effects of cyclosporin A on cultured mouse pancreatic islets. Diabetologia 1984; 27: 66.
7. Mieles L, Gordon RD, Mintz D, et al. Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients. Transplant Proc 1991; 23: 949.
8. Carroll PB, Strasser S, Alejandro R. The effect of FK 506 on cyclophosphamide-induced diabetes in the NOD mouse model. Transplant Proc 1991; 23: 3348.
9. Tze WJ, Tai J, Murase N, et al. Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. Transplant Proc 1991; 23: 3158.
10. Rilo HLR, Zeng R, Alejandro R, et al. Effect of FK 506 on func tion of human islets of Langerhans Transplant Proc 1991; 23: 3164.
11. Raine AE, Carter R, Mann JI, et al. Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients. Nephrol Dial Transplant 1988; 3: 458.
12. Harris KP, Russell GI, Parvin SD, et al. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J Clin Res Ed 1986; 292: 16.
13. Schom TF, Kliem V, Bojanovski M, et al. Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients. Transplant Int 1991; 4: 92.
14. Lake KD. Management of drug interactions with cyclosporine. Pharmacotherapy 1991; 11: 110S.
15. Morrisett JD, Northrup SR, Gotto AM Jr, et al. Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. Transplant Proc 1991; 23: 3185.
16. Starzl TE, Fung J, Jordon M, Shapiro R, et al. Kidney trans plantation under FK 506. JAMA 1990; 264: 63.
17. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes 1979; 28: 1039.
18. Lie RF, Schmith JM, Pierre KJ, Gochman N. Cholesterol oxi-dase-based determination by continous flow analysis of total and free cholesterol in serum. Clin Chem 1976; 22: 627.
19. Fossati P, Prencipe L. Serum triglycerides determined colo-metrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077.
20. The Lipids Research Clinics Population Studies Data Book, vol. 1 The Prevalence study. Bethesda, MD: National Institutes of Health, 1980: 1529.
21. NIH Consensus Development Panel. Lowering blood cholesterol to prevent heart disease. JAMA 1985; 253: 2080.
22. McGeown M, Douglas F, Brown W, et al. Advantages of low-dose steroid from the day after renal transplantation. Transplant 1980; 29: 287.
23. Gunnarsson R, Klintmalm G, Lundgren G, et al. Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporine. Transplant Proc 1984; 16: 709.
24. Alejandro R, Feldman EC, Bloom AD, et al. Diabetes 1989; 38: 698.
25. Yale JF, Chamelian M, Courchesne S, et al. Transplant Proc 1988; 20: 985.
26. Todo S, Fung JJ, Starzl TE, et al. Liver, kidney and thoracic organ transplantation under FK 506. Ann Surg 1990; 212: 295.
27. Ballantyne CM, Podet EJ, Patsch WP, et al. Effects of cyclospo rine therapy on plasma lipoprotein levels. JAMA 1989; 262: 53.
28. Platz KP, Mueller AR, Bechstein WO, Bachmann S, Blumhardt G, Neuhaus P. Nephrotoxicity following orthotopic liver transplantation, comparison between cyclosporine A and FK 506. Transplantation (in press).
29. Mueller AR, Platz KP, Bechstein WO, et al. Neurotoxicity fol lowing orthotopic liver transplantation. Comparison between cyclosporine A and FK 506. Transplantation (in press).
30. Siekierka JJ, Hung SHY, Poe M, et al. A cytosolic protein for the immunosuppressant FK 506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989; 341: 755.
31. Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989; 341: 758.
32. Fischer G, Bang J. The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochem Biophys Acta 1984; 828: 39.